ANDROGEN INSENSITIVITY SYNDROME DUE TO NEW MUTATIONS IN THE DNA-BINDING DOMAIN OF THE ANDROGEN RECEPTOR
Citation
K. Imasaki et al., ANDROGEN INSENSITIVITY SYNDROME DUE TO NEW MUTATIONS IN THE DNA-BINDING DOMAIN OF THE ANDROGEN RECEPTOR, Molecular and cellular endocrinology, 120(1), 1996, pp. 15-24
Categorie Soggetti
Endocrynology & Metabolism","Cell Biology
SICI code
0303-7207(1996)120:1<15:AISDTN>2.0.ZU;2-9
Abstract
Androgen insensitivity syndrome (AIS) is associated with a wide range
of quantitative or qualitative defects in the androgen receptor (AR).
In some patients with AIS, however, no defects are detectable in the l
igand-binding properties of the AR. We have analyzed the ARs of two un
related patients with this category (termed 'receptor-positive type')
of AIS. Sequence analysis of these patients' AR gene revealed single a
mino acid substitutions ((579)Cys(<T(G)under bar C>) --> Phe(<T(T)unde
r bar C>) and (582)Phe(<T(T)under bar C>) --> Tyr(<T(A)under bar C>))
in exon B encoding the first zinc finger of the DNA-binding domain of
the AR. These mutations have not been previously reported. Moreover, c
otransfection assays and mobility shift assays revealed that these pat
ients' mutant ARs had defective transcriptional activity of the target
gene because of impaired DNA-binding ability to the androgen-responsi
ve element. These findings strongly indicate that these mutations are
responsible for the pathogenesis of AIS in these patients.